化合物 Terazosin T61729
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
50 mg | 63590-64-7 | ¥13,800.00 | 询底价 |
25 mg | 63590-64-7 | ¥10,600.00 | 询底价 |
100 mg | 63590-64-7 | ¥17,500.00 | 询底价 |
Product Introduction
Bioactivity
英文名: Terazosin
描述: Terazosin, a quinazoline derivative, is an orally active and competitive antagonist of α1-adrenoceptors. Its mechanism of action involves relaxing blood vessels and promoting bladder opening. Terazosin exhibits therapeutic potential for treating benign prostatic hyperplasia (BPH) and high blood pressure [1][2][3].
体外活性: Terazosin does not discriminate cloned α1-adrenoceptor subtypes transiently expressed in COS cells [1].
体内活性: Terazosin can be used to promote stone discharge in treatment of ureteral stones. Terazosin is reportedly safe and effective in treatment of distal ureteral stones, especially stones >5 mm [3].
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
化合物 Terazosin T61729信息由TargetMol中国为您提供,如您想了解更多关于化合物 Terazosin T61729报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途